| 1 | insufficient | 5,646 |
| 2 | accumulating | 676 |
| 3 | low-quality | 574 |
| 4 | moderate-quality | 245 |
| 5 | mounting | 222 |
| 6 | ample | 175 |
| 7 | converging | 95 |
| 8 | circumstantial | 62 |
| 9 | low-strength | 31 |
| 10 | corroborative | 20 |
| 11 | very-low-quality | 19 |
| 12 | best-available | 10 |
| 13 | moderate-strength | 8 |
| 14 | incontrovertible | 7 |
| 15 | provider-reported | 7 |
| 16 | 'limited | 6 |
| 17 | irrefutable | 6 |
| 18 | 'insufficient | 4 |
| 19 | medium-quality | 4 |
| 20 | software-assisted | 4 |
| 21 | uncontested | 4 |
| 22 | level-c | 3 |
| 23 | found.the | 2 |
| 24 | strong-moderate | 2 |
| 25 | very-low-strength | 2 |
| 26 | 'rigorous | 1 |
| 27 | analyses.more | 1 |
| 28 | angiographic/pathological | 1 |
| 29 | bacillopeptidase | 1 |
| 30 | biochemical-electrocardiographic | 1 |
| 31 | chromothripsis-like | 1 |
| 32 | ct-visible | 1 |
| 33 | dichotomous/ordinal | 1 |
| 34 | direct-to-physician | 1 |
| 35 | diseaseoriented | 1 |
| 36 | drug.the | 1 |
| 37 | fibromyalgia.second-tier | 1 |
| 38 | function.low-quality | 1 |
| 39 | here.moderate-quality | 1 |
| 40 | highest.further | 1 |
| 41 | inadequte | 1 |
| 42 | incontrovertable | 1 |
| 43 | insufficeint | 1 |
| 44 | low-to-moderate-quality | 1 |
| 45 | lymphographic | 1 |
| 46 | notropis | 1 |
| 47 | observational-derived | 1 |
| 48 | physician-verified | 1 |
| 49 | ponderable | 1 |
| 50 | poor.further | 1 |
| 51 | radiological/clinical | 1 |
| 52 | rapidly-emerging | 1 |
| 53 | rates.low-quality | 1 |
| 54 | required.rct | 1 |
| 55 | requirements.the | 1 |
| 56 | rock-solid | 1 |
| 57 | scintigraphy-based | 1 |
| 58 | scrologic | 1 |
| 59 | supplementation.the | 1 |
| 60 | treatment.epidemiological | 1 |
| 61 | validity-related | 1 |
| 62 | weak-moderate | 1 |
| 1 | 'insufficient | 4 |
| 2 | 'limited | 6 |
| 3 | 'rigorous | 1 |
| 4 | accumulating | 676 |
| 5 | ample | 175 |
| 6 | analyses.more | 1 |
| 7 | angiographic/pathological | 1 |
| 8 | bacillopeptidase | 1 |
| 9 | best-available | 10 |
| 10 | biochemical-electrocardiographic | 1 |
| 11 | chromothripsis-like | 1 |
| 12 | circumstantial | 62 |
| 13 | converging | 95 |
| 14 | corroborative | 20 |
| 15 | ct-visible | 1 |
| 16 | dichotomous/ordinal | 1 |
| 17 | direct-to-physician | 1 |
| 18 | diseaseoriented | 1 |
| 19 | drug.the | 1 |
| 20 | fibromyalgia.second-tier | 1 |
| 21 | found.the | 2 |
| 22 | function.low-quality | 1 |
| 23 | here.moderate-quality | 1 |
| 24 | highest.further | 1 |
| 25 | inadequte | 1 |
| 26 | incontrovertable | 1 |
| 27 | incontrovertible | 7 |
| 28 | insufficeint | 1 |
| 29 | insufficient | 5,646 |
| 30 | irrefutable | 6 |
| 31 | level-c | 3 |
| 32 | low-quality | 574 |
| 33 | low-strength | 31 |
| 34 | low-to-moderate-quality | 1 |
| 35 | lymphographic | 1 |
| 36 | medium-quality | 4 |
| 37 | moderate-quality | 245 |
| 38 | moderate-strength | 8 |
| 39 | mounting | 222 |
| 40 | notropis | 1 |
| 41 | observational-derived | 1 |
| 42 | physician-verified | 1 |
| 43 | ponderable | 1 |
| 44 | poor.further | 1 |
| 45 | provider-reported | 7 |
| 46 | radiological/clinical | 1 |
| 47 | rapidly-emerging | 1 |
| 48 | rates.low-quality | 1 |
| 49 | required.rct | 1 |
| 50 | requirements.the | 1 |
| 51 | rock-solid | 1 |
| 52 | scintigraphy-based | 1 |
| 53 | scrologic | 1 |
| 54 | software-assisted | 4 |
| 55 | strong-moderate | 2 |
| 56 | supplementation.the | 1 |
| 57 | treatment.epidemiological | 1 |
| 58 | uncontested | 4 |
| 59 | validity-related | 1 |
| 60 | very-low-quality | 19 |
| 61 | very-low-strength | 2 |
| 62 | weak-moderate | 1 |
| 1 | level-c | 3 |
| 2 | scrologic | 1 |
| 3 | lymphographic | 1 |
| 4 | biochemical-electrocardiographic | 1 |
| 5 | physician-verified | 1 |
| 6 | scintigraphy-based | 1 |
| 7 | validity-related | 1 |
| 8 | 'limited | 6 |
| 9 | diseaseoriented | 1 |
| 10 | provider-reported | 7 |
| 11 | uncontested | 4 |
| 12 | software-assisted | 4 |
| 13 | observational-derived | 1 |
| 14 | rock-solid | 1 |
| 15 | found.the | 2 |
| 16 | drug.the | 1 |
| 17 | supplementation.the | 1 |
| 18 | requirements.the | 1 |
| 19 | chromothripsis-like | 1 |
| 20 | best-available | 10 |
| 21 | ponderable | 1 |
| 22 | incontrovertable | 1 |
| 23 | irrefutable | 6 |
| 24 | ct-visible | 1 |
| 25 | incontrovertible | 7 |
| 26 | ample | 175 |
| 27 | analyses.more | 1 |
| 28 | bacillopeptidase | 1 |
| 29 | strong-moderate | 2 |
| 30 | weak-moderate | 1 |
| 31 | inadequte | 1 |
| 32 | corroborative | 20 |
| 33 | rapidly-emerging | 1 |
| 34 | converging | 95 |
| 35 | accumulating | 676 |
| 36 | mounting | 222 |
| 37 | moderate-strength | 8 |
| 38 | low-strength | 31 |
| 39 | very-low-strength | 2 |
| 40 | angiographic/pathological | 1 |
| 41 | treatment.epidemiological | 1 |
| 42 | radiological/clinical | 1 |
| 43 | circumstantial | 62 |
| 44 | dichotomous/ordinal | 1 |
| 45 | direct-to-physician | 1 |
| 46 | poor.further | 1 |
| 47 | highest.further | 1 |
| 48 | fibromyalgia.second-tier | 1 |
| 49 | notropis | 1 |
| 50 | 'rigorous | 1 |
| 51 | required.rct | 1 |
| 52 | insufficient | 5,646 |
| 53 | 'insufficient | 4 |
| 54 | insufficeint | 1 |
| 55 | moderate-quality | 245 |
| 56 | low-to-moderate-quality | 1 |
| 57 | here.moderate-quality | 1 |
| 58 | medium-quality | 4 |
| 59 | low-quality | 574 |
| 60 | very-low-quality | 19 |
| 61 | function.low-quality | 1 |
| 62 | rates.low-quality | 1 |